Predictions
D-wave Quantum Inc.
Start price
Target price
Perf. (%)
€1.70
14.02.24
14.02.24
€1.00
14.02.25
14.02.25
12.69%
15.02.24
15.02.24
Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
D-wave Quantum Inc.
Start price
Target price
Perf. (%)
€1.35
13.02.24
13.02.24
€1.00
13.02.25
13.02.25
26.07%
14.02.24
14.02.24
Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
D-wave Quantum Inc.
Start price
Target price
Perf. (%)
€1.11
12.02.24
12.02.24
€1.00
12.02.25
12.02.25
21.40%
13.02.24
13.02.24
Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Tc Biopharm (holdings) Plc
Start price
Target price
Perf. (%)
€1.56
09.02.24
09.02.24
-
09.02.25
09.02.25
-39.10%
18.02.24
18.02.24
Could be worthwhile Investment >10% per year
Wimi Hologram Cloud Inc.
Start price
Target price
Perf. (%)
€1.02
08.02.24
08.02.24
-
08.02.25
08.02.25
27.45%
17.02.24
17.02.24
Could be worthwhile Investment >10% per year
Wimi Hologram Cloud Inc.
Start price
Target price
Perf. (%)
€1.09
08.02.24
08.02.24
-
08.02.25
08.02.25
19.27%
17.02.24
17.02.24
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Little innovation
Biorestorative Therapies Inc.
Start price
Target price
Perf. (%)
€1.36
06.02.24
06.02.24
-
06.02.25
06.02.25
2.21%
17.02.24
17.02.24
Capable Management
Could be worthwhile Investment >10% per year
Good culture
Few uniques
Uipath Inc.
Start price
Target price
Perf. (%)
€20.90
05.02.24
05.02.24
€30.00
05.02.25
05.02.25
8.61%
17.02.24
17.02.24
EBIT growth >5% per year expected
Top 10 in its market
Good rating
Standard Investments for future growth
Affirm Hldgs Inc
Start price
Target price
Perf. (%)
€38.10
05.02.24
05.02.24
€50.00
05.02.25
05.02.25
-6.82%
17.02.24
17.02.24
EBIT growth >5% per year expected
Standard Investments for future growth
Some uniques
Could be very worthwhile Investment >20% year
Li-ft Power Ltd.
Start price
Target price
Perf. (%)
€3.23
05.02.24
05.02.24
€10.00
05.02.25
05.02.25
-3.41%
17.02.24
17.02.24
Good rating
High Investments for future growth
Revenue growth > 30% per year expected
Sustainability is little important
Top Ships Inc.
Start price
Target price
Perf. (%)
€12.40
05.02.24
05.02.24
€26.00
05.02.25
05.02.25
1.61%
27.02.24
27.02.24
Could be very worthwhile Investment >20% year
Cantourage Group SE
Start price
Target price
Perf. (%)
€10.50
05.02.24
05.02.24
-
05.02.25
05.02.25
-16.29%
17.02.24
17.02.24
Risky Investment
Addex Therapeutics Sa
Start price
Target price
Perf. (%)
€9.00
04.02.24
04.02.24
€12.00
31.05.25
31.05.25
148.89%
15.04.24
15.04.24
Could be very worthwhile Investment >20% year
D-wave Quantum Inc.
Start price
Target price
Perf. (%)
€0.92
03.02.24
03.02.24
€1.00
03.02.25
03.02.25
20.87%
12.02.24
12.02.24
Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Annovis Bio Inc.
Start price
Target price
Perf. (%)
€9.89
02.02.24
02.02.24
-
02.02.25
02.02.25
-5.26%
03.02.24
03.02.24
Risky Investment
D-wave Quantum Inc.
Start price
Target price
Perf. (%)
€0.83
31.01.24
31.01.24
€0.000
31.01.25
31.01.25
11.38%
03.02.24
03.02.24
Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Lava Therapeutics B.v.
Start price
Target price
Perf. (%)
€1.94
25.01.24
25.01.24
€2.00
25.01.25
25.01.25
-20.10%
03.02.24
03.02.24
Could be worthwhile Investment >10% per year
Good culture
Innovative
No uniques
Lava Therapeutics B.v.
Start price
Target price
Perf. (%)
€1.97
25.01.24
25.01.24
€2.80
25.01.25
25.01.25
14.72%
25.01.24
25.01.24
Could be very worthwhile Investment >20% year
Kodiak Sciences Inc.
Start price
Target price
Perf. (%)
€3.57
25.01.24
25.01.24
€4.80
31.08.25
31.08.25
24.28%
25.01.24
25.01.24
Could be very worthwhile Investment >20% year
Redhill Biopharma Ltd.
Start price
Target price
Perf. (%)
€1.00
24.01.24
24.01.24
-
24.01.25
24.01.25
-49.20%
03.02.24
03.02.24
Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
No Innovation
Uipath Inc.
Start price
Target price
Perf. (%)
€21.70
22.01.24
22.01.24
€25.00
22.01.25
22.01.25
2.77%
03.02.24
03.02.24
EBIT growth >5% per year expected
Top 10 in its market
Good rating
Standard Investments for future growth
Mereo Biopharma Group Ltd.
Start price
Target price
Perf. (%)
€2.98
21.01.24
21.01.24
-
21.01.25
21.01.25
19.46%
03.02.24
03.02.24
Could be worthwhile Investment >10% per year
Annovis Bio Inc.
Start price
Target price
Perf. (%)
€10.58
20.01.24
20.01.24
€5.00
30.04.25
30.04.25
-18.34%
25.01.24
25.01.24
Could be very worthwhile Investment >20% year